With Sales Up and Costs Down, Novartis CEO Rewards His Staff With Layoffs. By Jim Edwards Updated on: November 23, 2010 / 10:33 AM / MoneyWatch Novartis (NVS) CEO Joe Jimenez ...
It was no surprise that a federal jury in New York reached a $3.36 million verdict today in favor of a class-action sex discrimination case against Novartis (NVS) -- one trial witness was a woman ...
Companies there compete for employees with their larger state sectors, which often still offer defined benefit pensions. And, generally, Northern European companies like Novartis are rather more ...
Novartis AG (NVS) said the FDA extended the review period for its investigational multiple sclerosis (MS) drug Gilenia by three months. Given the unexplained "refuse-to-file" letter received by a ...
A dynamic professional with 3 years of experience in LMS. Deft at handling tickets ... Senior Executive Human Resources at Reliance Nippon Life Insurance.
Adding Novartis' (NVS) blood-pressure medication Tekturna (aliskiren) to standard medical therapy in patients recovering from a heart attack doesn't offer additional benefit and could result in ...
Novartis (NVS) CEO Joe Jimenez's strategy of not talking about layoffs -- while laying off thousands -- seems to be backfiring.A Swiss newspaper called him "Der diskrete Jobkiller" after doing ...